---
figid: PMC6478618__WJG-25-1783-g002
figlink: /pmc/articles/PMC6478618/figure/F2/
number: F2
caption: 'Nonalcoholic fatty liver disease-Kyoto Encyclopedia of Genes and Genomes
  pathway and mechanisms of disease pathogenesis. Pathway was retrieved from https://www.genome.jp/dbget-bin/www_bget?pathway+hsa04932;
  figure was modified to highlight key molecular processes. This map shows a stage-dependent
  progression of nonalcoholic fatty liver disease (NAFLD). In the first stage of NAFLD,
  pathway highlights excess lipid accumulation associated with the induction of insulin
  resistance, which leads to a defect in insulin suppression of free fatty acids (FAAs)
  disposal. In addition, two transcription factors, SREBP-1c and PPARα, activate key
  enzymes of lipogenesis and increase the synthesis of FAAs in liver. In the second
  stage, pathway is presented as a consequence of the progression to nonalcoholic
  steatohepatitis (NASH); the production of reactive oxygen species is enhanced due
  to oxidation stress through mitochondrial beta-oxidation of fatty acids and endoplasmic
  reticulum (ER) stress, leading to lipid peroxidation. The lipid peroxidation can
  further cause the production of cytokines [Fas ligand, tumor necrosis factor α (TNF-α),
  IL-8 and transforming growth factor], promoting cell death, inflammation and fibrosis.
  The activation of JNK, which is induced by ER stress, TNF-α and FAAs, is also associated
  with NAFLD progression. Increased JNK promotes cytokine production and initiation
  of hepatocellular carcinoma. Major organelles involved in the pathogenesis of NASH
  are also highlighted in the NAFLD-pathway, including mitochondria and mitochondrial
  dysfunction. In the figure, molecular targets that were further selected to explore
  protein-chemical interactions are highlighted by red squares. NAFLD: Nonalcoholic
  fatty liver disease; NASH: Nonalcoholic steatohepatitis; ER: Endoplasmic reticulum;
  HCC: Hepatocellular carcinoma; NAFL: Nonalcoholic fatty liver; FAAs: Free fatty
  acids; TNFα: tumor necrosis factor α.'
pmcid: PMC6478618
papertitle: Repurposing drugs to target nonalcoholic steatohepatitis.
reftext: Silvia Sookoian, et al. World J Gastroenterol. 2019 Apr 21;25(15):1783-1796.
pmc_ranked_result_index: '51480'
pathway_score: 0.9454296
filename: WJG-25-1783-g002.jpg
figtitle: Nonalcoholic fatty liver disease-Kyoto Encyclopedia of Genes and Genomes
  pathway and mechanisms of disease pathogenesis
year: '2019'
organisms:
- Homo sapiens
ndex: 2d605e09-def7-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6478618__WJG-25-1783-g002.html
  '@type': Dataset
  description: 'Nonalcoholic fatty liver disease-Kyoto Encyclopedia of Genes and Genomes
    pathway and mechanisms of disease pathogenesis. Pathway was retrieved from https://www.genome.jp/dbget-bin/www_bget?pathway+hsa04932;
    figure was modified to highlight key molecular processes. This map shows a stage-dependent
    progression of nonalcoholic fatty liver disease (NAFLD). In the first stage of
    NAFLD, pathway highlights excess lipid accumulation associated with the induction
    of insulin resistance, which leads to a defect in insulin suppression of free
    fatty acids (FAAs) disposal. In addition, two transcription factors, SREBP-1c
    and PPARα, activate key enzymes of lipogenesis and increase the synthesis of FAAs
    in liver. In the second stage, pathway is presented as a consequence of the progression
    to nonalcoholic steatohepatitis (NASH); the production of reactive oxygen species
    is enhanced due to oxidation stress through mitochondrial beta-oxidation of fatty
    acids and endoplasmic reticulum (ER) stress, leading to lipid peroxidation. The
    lipid peroxidation can further cause the production of cytokines [Fas ligand,
    tumor necrosis factor α (TNF-α), IL-8 and transforming growth factor], promoting
    cell death, inflammation and fibrosis. The activation of JNK, which is induced
    by ER stress, TNF-α and FAAs, is also associated with NAFLD progression. Increased
    JNK promotes cytokine production and initiation of hepatocellular carcinoma. Major
    organelles involved in the pathogenesis of NASH are also highlighted in the NAFLD-pathway,
    including mitochondria and mitochondrial dysfunction. In the figure, molecular
    targets that were further selected to explore protein-chemical interactions are
    highlighted by red squares. NAFLD: Nonalcoholic fatty liver disease; NASH: Nonalcoholic
    steatohepatitis; ER: Endoplasmic reticulum; HCC: Hepatocellular carcinoma; NAFL:
    Nonalcoholic fatty liver; FAAs: Free fatty acids; TNFα: tumor necrosis factor
    α.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FOS
  - FOSB
  - AKT3
  - AKT1
  - AKT2
  - ADIPOQ
  - PRKAG1
  - IL6
  - IL6R
  - INS
  - INSR
  - FOSL2
  - JUN
  - JUNB
  - PRKAG2
  - PRKAG3
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - IL1B
  - PPARD
  - PPARG
  - RXRA
  - RXRB
  - RXRG
  - SOCS3
  - SREBF1
  - TNF
  - PRKAA1
  - IKBKB
  - IL1A
  - PPARA
  - CASP7
  - CASP8
  - CASP9
  - CASP10
  - EBP
  - DDIT3
  - MLXIPL
  - CYP2E1
  - FAS
  - FASLG
  - FAM126A
  - FOSL1
  - MAP3K5
  - ATF4
  - BAX
  - BID
  - BCL2L11
  - CASP3
  - IRS2
  - ITCH
  - LEP
  - NR1H3
  - JUND
  - CASP4
  - CASP5
  - CASP6
  - XBP1
  - CASP1
  - CASP12
  - CASP14
  - MAP3K11
  - NFKB1
  - CASP2
  - EIF2AK3
  - UNKL
  - LEPR
  - TRAF2
  - TNFRSF1A
  - Oxysterol
  - Fatty acid
  - Glucose
  - ITCH
  - Fatty acids
  - Acyl-Co
  - diabetes
  - insulin - Hyperinsulinemia
  - Fibrosis
  - "Cirhosis  Hepatocyte injury"
  - Non-akoholc fatty ver disease
genes:
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: ACDC
  symbol: ACDC
  source: hgnc_prev_symbol
  hgnc_symbol: ADIPOQ
  entrez: '9370'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IL-6R
  symbol: IL6R
  source: hgnc_symbol
  hgnc_symbol: IL6R
  entrez: '3570'
- word: INS
  symbol: INS
  source: hgnc_symbol
  hgnc_symbol: INS
  entrez: '3630'
- word: INSR
  symbol: INSR
  source: hgnc_symbol
  hgnc_symbol: INSR
  entrez: '3643'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: IL-1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: PPAR-
  symbol: PPAR
  source: bioentities_symbol
  hgnc_symbol: PPARD
  entrez: '5467'
- word: PPAR-
  symbol: PPAR
  source: bioentities_symbol
  hgnc_symbol: PPARG
  entrez: '5468'
- word: RXR
  symbol: RXR
  source: bioentities_symbol
  hgnc_symbol: RXRA
  entrez: '6256'
- word: RXR
  symbol: RXR
  source: bioentities_symbol
  hgnc_symbol: RXRB
  entrez: '6257'
- word: RXR
  symbol: RXR
  source: bioentities_symbol
  hgnc_symbol: RXRG
  entrez: '6258'
- word: SOCS3
  symbol: SOCS3
  source: hgnc_symbol
  hgnc_symbol: SOCS3
  entrez: '9021'
- word: SREBP-1c
  symbol: SREBP-1c
  source: hgnc_alias_symbol
  hgnc_symbol: SREBF1
  entrez: '6720'
- word: TNF
  symbol: TNF
  source: hgnc_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: TNFa
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: IKKB
  symbol: IKK-beta
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: IL-1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1A
  entrez: '3552'
- word: PPAR-
  symbol: PPAR
  source: bioentities_symbol
  hgnc_symbol: PPARA
  entrez: '5465'
- word: caspases
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: caspases
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: caspases
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: caspases
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: C/EBP
  symbol: EBP
  source: hgnc_symbol
  hgnc_symbol: EBP
  entrez: '10682'
- word: CHOP
  symbol: CHOP
  source: hgnc_alias_symbol
  hgnc_symbol: DDIT3
  entrez: '1649'
- word: CHREBP
  symbol: CHREBP
  source: hgnc_alias_symbol
  hgnc_symbol: MLXIPL
  entrez: '51085'
- word: CYP2E
  symbol: CYP2E
  source: hgnc_prev_symbol
  hgnc_symbol: CYP2E1
  entrez: '1571'
- word: Fas
  symbol: FAS
  source: hgnc_symbol
  hgnc_symbol: FAS
  entrez: '355'
- word: Fasl
  symbol: FasL
  source: hgnc_alias_symbol
  hgnc_symbol: FASLG
  entrez: '356'
- word: HCC
  symbol: HCC
  source: hgnc_alias_symbol
  hgnc_symbol: FAM126A
  entrez: '84668'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: ASK1
  symbol: ASK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP3K5
  entrez: '4217'
- word: ATF4
  symbol: ATF4
  source: hgnc_symbol
  hgnc_symbol: ATF4
  entrez: '468'
- word: Bax
  symbol: BAX
  source: hgnc_symbol
  hgnc_symbol: BAX
  entrez: '581'
- word: Bid
  symbol: BID
  source: hgnc_symbol
  hgnc_symbol: BID
  entrez: '637'
- word: Bim
  symbol: BIM
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L11
  entrez: '10018'
- word: CASP3
  symbol: CASP3
  source: hgnc_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: IRS-1/2
  symbol: IRS2
  source: hgnc_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: ITCH
  symbol: ITCH
  source: hgnc_symbol
  hgnc_symbol: ITCH
  entrez: '83737'
- word: Jun
  symbol: JUN
  source: hgnc_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: LEP
  symbol: LEP
  source: hgnc_symbol
  hgnc_symbol: LEP
  entrez: '3952'
- word: LXR-a
  symbol: LXR-a
  source: hgnc_alias_symbol
  hgnc_symbol: NR1H3
  entrez: '10062'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: caspases
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: caspases
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: caspases
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: (XBP1
  symbol: XBP1
  source: hgnc_symbol
  hgnc_symbol: XBP1
  entrez: '7494'
- word: caspases
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: caspases
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: caspases
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: CASP7
  symbol: CASP7
  source: hgnc_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: caspases
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: MLK3
  symbol: MLK3
  source: hgnc_prev_symbol
  hgnc_symbol: MAP3K11
  entrez: '4296'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: caspases
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: PERK
  symbol: PERK
  source: hgnc_alias_symbol
  hgnc_symbol: EIF2AK3
  entrez: '9451'
- word: UNKL/2
  symbol: UNKL
  source: hgnc_symbol
  hgnc_symbol: UNKL
  entrez: '64718'
- word: ObR
  symbol: OBR
  source: hgnc_alias_symbol
  hgnc_symbol: LEPR
  entrez: '3953'
- word: TRAF2
  symbol: TRAF2
  source: hgnc_symbol
  hgnc_symbol: TRAF2
  entrez: '7186'
- word: TNFRI
  symbol: TNF-R-I
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF1A
  entrez: '7132'
chemicals:
- word: Oxysterol
  source: MESH
  identifier: C083714
- word: Fatty acid
  source: MESH
  identifier: D005227
- word: Glucose
  source: MESH
  identifier: D005947
- word: ITCH
  source: ''
  identifier: ''
- word: Fatty acids
  source: MESH
  identifier: D005227
- word: Acyl-Co
  source: MESH
  identifier: D000214
diseases:
- word: diabetes
  source: MESH
  identifier: D003920
- word: insulin - Hyperinsulinemia
  source: MESH
  identifier: D006946
- word: Fibrosis
  source: MESH
  identifier: D005355
- word: "Cirhosis  Hepatocyte injury"
  source: MESH
  identifier: D058186
- word: Non-akoholc fatty ver disease
  source: MESH
  identifier: D065626
figid_alias: PMC6478618__F2
redirect_from: /figures/PMC6478618__F2
figtype: Figure
---
